Open access · CC-BY
via OpenAlex
Notch signaling pathway: architecture, disease, and therapeutics
Binghan Zhou, Wanling Lin, Yaling Long, Yunkai Yang, Huan Zhang, Kongming Wu, Qian Chu
Signal Transduction and Targeted Therapy · 2022 · ▲ 1,041 citations
Abstract
The NOTCH gene was identified approximately 110 years ago. Classical studies have revealed that NOTCH signaling is an evolutionarily conserved pathway. NOTCH receptors undergo three cleavages and translocate into the nucleus to regulate the transcription of target genes. NOTCH signaling deeply participates in the development and homeostasis of multiple tissues and organs, the aberration of which results in cancerous and noncancerous diseases. However, recent studies indicate that the outcomes of NOTCH signaling are changeable and highly dependent on context. In terms of cancers, NOTCH signaling can both promote and inhibit tumor development in various types of cancer. The overall performance of NOTCH-targeted therapies in clinical trials has failed to meet expectations. Additionally, NOTCH mutation has been proposed as a predictive biomarker for immune checkpoint blockade therapy in many cancers. Collectively, the NOTCH pathway needs to be integrally assessed with new perspectives to inspire discoveries and applications. In this review, we focus on both classical and the latest findings related to NOTCH signaling to illustrate the history, architecture, regulatory mechanisms, contributions to physiological development, related diseases, and therapeutic applications of the NOTCH pathway. The contributions of NOTCH signaling to the tumor immune microenvironment and cancer immunotherapy are also highlighted. We hope this review will help not only beginners but also experts to systematically and thoroughly understand the NOTCH signaling pathway.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/s41392-022-00934-y
- Canonical
- link ↗
- Fetched
- 2026-06-07 MST
Cite this
APA
Zhou, B., Lin, W., Long, Y., Yang, Y., Zhang, H., Wu, K., & Chu, Q. (2022). Notch signaling pathway: architecture, disease, and therapeutics. <em>Signal Transduction and Targeted Therapy</em>. https://doi.org/10.1038/s41392-022-00934-y
Vancouver
Zhou B, Lin W, Long Y, Yang Y, Zhang H, Wu K, et al. Notch signaling pathway: architecture, disease, and therapeutics. Signal Transduction and Targeted Therapy. 2022. doi:10.1038/s41392-022-00934-y.
BibTeX
@article{binghan2022Notchs,
title = {Notch signaling pathway: architecture, disease, and therapeutics},
author = {Binghan Zhou and Wanling Lin and Yaling Long and Yunkai Yang and Huan Zhang and Kongming Wu and Qian Chu},
journal = {Signal Transduction and Targeted Therapy},
year = {2022},
doi = {10.1038/s41392-022-00934-y},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Ageing and Cancer Research & Treatment 2026
Open access · CC-BY
Interplay between hypoxia and inflammation in cancer progression, therapy resistance, and natural cancer resistance
Cancers 2018
Open access · CC-BY
mTOR Cross-Talk in Cancer and Potential for Combination Therapy
MDPI eBooks 2019
Open access · CC-BY
mTOR in Human Diseases
Frontiers in Endocrinology 2024
Open access · CC-BY
A narrative review on inflammaging and late-onset hypogonadism
Genes & Development 2006
Preprint · OA
Extension of chronological life span in yeast by decreased TOR pathway signaling
Antioxidants and Redox Signaling 2016
Open access · CC-BY